A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS for children and adults living with Lennox–Gastaut syndrome (LGS).
Associate Professor Ailsa McGregor from the University of Otago's School of Pharmacy has set on a mission to enhance the efficacy and safety of lithium treatment for patients battling bipolar disorder (BD).
A recent multicenter randomised clinical trial has cast doubt on the efficacy of vaginal micronised progesterone (VMP) in preventing preterm birth in women with arrested preterm labour (APTL).
Researchers at the University of Notre Dame have a development in cancer therapy: a miniature, wireless LED device that can be implanted directly into deep-seated tumours.
The NHS Business Services Authority (NHSBSA) has disclosed its annual report detailing the prescription trends for mental health medications in England, covering the financial...
In a new effort to revolutionise treatment for eye injuries and disorders, a team of researchers from the University of Liverpool have secured £2.1 million in funding.
A recent advisory panel to the Food and Drug Administration (FDA) has cast significant doubt on the potential approval of MDMA-assisted therapy for post-traumatic stress disorder (PTSD).
In June, Alzheimer's and brain awareness month, Mayo Clinic researchers have identified unique molecular signatures of blood-brain barrier dysfunction in Alzheimer's disease.
Imagine a world where children's medicine tastes like chocolate, seniors can take just one pill for all their daily medications, and you can get a drug made specifically for your unique health needs right at your local pharmacy.
Scientists have developed new types of fibers that could revolutionize medical treatments. Made from a biodegradable polymer PLA (plastic) and reinforced with special nanoparticles, these fibers show great promise for use in medical implants, improved healing, reduced infection risk, and a wider range of medical applications.
In a study, researchers from the University of Basel and the University Hospital Basel have uncovered a promising new approach to combat the Epstein-Barr virus (EBV), a common virus that affects 90% of the adult population.
The University of Michigan Health Rogel Cancer Center has revealed that changing the dosing schedule for common cancer therapy could greatly reduce greenhouse gas emissions without compromising the patient's outcomes.
